Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CME Programs Endure As Industry Funding, Number Of Providers Declines

Executive Summary

Accreditation Council for Continuing Medical Education reports that commercial support for CME activities declined in 2011 but the number of activities increased 3.8%; more than 20 million participated in CME programs.

You may also be interested in...



CME Funding Not Reportable Under Sunshine Law, But Bias Debate Continues

ACCME report finds “no evidence to support or refute” belief that commercial support creates commercial bias in CME activities.

CMS Plan To Remove Speaker Payment Disclosure Exemption: Stigmatizing Or Administrative?

A proposal by CMS to remove an explicit exemption from Open Payments/Sunshine Act disclosure requirements for certain continuing medical education speakers will unnecessarily stigmatize physicians, says a CME industry group, but CMS and others suggest the proposed change will not have much, if any, practical impact on physicians or companies.

Medical Education Speaker Payments May See More Disclosure Under Sunshine Revisions

CME payments had been excluded if event met standards of specified accrediting organizations, but CMS proposes to eliminate exemption due in part to concern that agency may appear to be endorsing certain events.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS054689

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel